Leishmania parasites secrete a variety of proteins that are modified by phosphoglycan chains structurally similar to those of the cell surface glycolipid lipophosphoglycan. These proteins are collectively called proteophosphoglycans. We report here the cloning and sequencing of a novel Leishmania major proteophosphoglycan gene, ppg1. It encodes a large polypeptide of approximately 2300 amino acids. The N-terminal domain of approximately 70 kDa exhibits 11 imperfect amino acid repeats that show some homology to promastigote surface glycoproteins of the psa2/ gp46 complex. The large central domain apparently consists exclusively of approximately 100 repetitive peptides of the sequence APSASSSSA(P/S)SSSSS(؎S). Gene fusion experiments demonstrate that these peptide repeats are the targets of phosphoglycosylation in Leishmania and that they form extended filamentous structures reminiscent of mammalian mucins. The C-terminal domain contains a functional glycosylphosphatidylinositol anchor addition signal sequence, which confers cell surface localization to a normally secreted Leishmania acid phosphatase, when fused to its C terminus. Antibody binding studies show that the ppg1 gene product is phosphoglycosylated by phosphoglycan repeats and cap oligosaccharides. In contrast to previously characterized proteophosphoglycans, the ppg1 gene product is predominantly membrane-associated and it is expressed on the promastigote cell surface. Therefore this membrane-bound proteophosphoglycan may be important for direct host-parasite interactions.Leishmania are kinetoplastid protozoan parasites with a digenetic life cycle and are responsible for several important human diseases, ranging from mild skin ulcers to fatal visceral disease. Several forms of extracellular flagellated Leishmania promastigotes colonize the digestive tract of vector sandflies. After transmission to the mammalian host by the bite of the insect, the parasites transform to the obligatory intracellular, nonflagellated amastigotes, which reside in the phagolysosomes of macrophages (1). Both Leishmania life stages synthesize complex and unique glycoconjugates, which are either displayed on their surface (2) or secreted (3). These glycoconjugates, which are thought to have crucial functions for parasite survival, development, and virulence in the sandfly vector and the mammalian macrophage, include a family of phosphoglycan-modified molecules, which comprises lipid-linked, protein-linked, and unlinked forms (4 -6). Lipophosphoglycan (LPG) 1 is the best studied representative of this family: it consists of 1-alkyl-2-lyso-phosphatidylinositol that is linked via a diphosphoheptasaccharide core to a linear polymer of up to 40 phosphodiester-linked disaccharides that are modified by species-, strain-, and stage-specific side chains. The polymer chain terminates with variable neutral cap oligosaccharides (2).